|
|
|
We Represent Leading Regulatory Experts Formerly with the FDA
|
|
|
|
|
|
Our expert team includes former agency officials who understand the full regulatory lifecycle—from clinical development and FDA approval to post-market compliance, manufacturing standards, and labeling requirements.
|
|
|
|
We represent leading testifying experts with unparalleled knowledge of FDA regulatory processes, compliance, and enforcement. We have assembled a multidisciplinary team of former FDA leaders whose agency experience spans drug, biologics, and medical device regulation.
|
|
Our former FDA experts can provide targeted expertise in:
|
-
FDA Regulatory Interpretations & Practices: Authoritative explanation of FDA regulatory interpretations and internal practices critical to litigation
-
Clinical & Nonclinical Data Evaluation: Expert assessment of the scientific rigor of clinical trials and nonclinical studies relevant to product safety, effectiveness, and contractual obligations
-
FDA Approval Pathways & Exclusivity Issues: Strategic insights into FDA approval processes, market exclusivity, and regulatory timelines impacting competitive dynamics
-
Risk Management & REMS Compliance: Thorough analysis of compliance with FDA-mandated risk mitigation strategies relevant to regulatory adherence or misrepresentation claims
-
Post-market Surveillance & Safety Reporting: Expert evaluation of pharmacovigilance practices, adverse event reporting compliance, and post-market regulatory requirements
-
Manufacturing Compliance (CMC & GMP): Deep expertise in FDA inspections, quality standards, manufacturing processes, and compliance issues affecting disputes and regulatory enforcement
|
|
Contact us to learn more about our testifying experts.
|
|
WIT Legal Joins DOAR
|
|
DOAR and WIT Legal (WIT) are joining forces, bringing together leading trial strategy consulting experts and the most qualified testifying expert witnesses under one roof.
|
|
Stay tuned for the launch of our new website in January 2026.
|
|
|
|
|
|
WITlegal.com
|
|
|